Finance

Lists
PTX:ASX
Prescient Therapeutics Ltd
A$0.069
+1.47%
(+0.00100) 1D
Sep 14, 10:44:11 AM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.07
Mkt. cap
70.48M
Avg. vol.
991.36K
Volume
353.29K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.07
Mkt. cap
70.48M
Avg. vol.
991.36K
Volume
353.29K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
578.89K
578.89K
1.15M
1.15M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.24M
1.24M
1.40M
1.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.13M
1.13M
1.20M
1.20M
Operating expense
2.57M
2.57M
2.73M
2.73M
Total operating expenses
2.57M
2.57M
2.73M
2.73M
Operating income
-1.99M
-1.99M
-1.58M
-1.58M
Other non operating income
-
-
-
-
EBT including unusual items
-1.99M
-1.99M
-1.51M
-1.51M
EBT excluding unusual items
-1.99M
-1.99M
-1.51M
-1.51M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.99M
-1.99M
-1.51M
-1.51M
Net profit margin
-344.35%
-344.35%
-131.51%
-131.51%
Earnings per share
-
-
-
-
Interest and investment income
1.86K
1.86K
67.39K
67.39K
Interest expense
-2.97K
-2.97K
-2.38K
-2.38K
Net interest expenses
-1.12K
-1.12K
65.02K
65.02K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-1.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps